The Amblyopia Market is Projected To Reach USD 6.5 billion By 2030, From USD 4.61 billion in 2022,Registering a CAGR Of 4.20% During The Forecast Period 2023-2030| Data By Contrive Datum Insights Pvt Ltd.
May 10, 2023 00:00 ET
|
Contrive Datum Insights Pvt Ltd
Farmington, May 10, 2023 (GLOBE NEWSWIRE) -- The Global Amblyopia Market size was valued at USD 4.61 billion in 2022 and is projected to reach USD 6.5 billion by 2030, growing at a CAGR of 4.20%...
Design Therapeutics Provides Pipeline Updates and Reports First Quarter 2023 Financial Results
May 09, 2023 16:05 ET
|
Design Therapeutics, Inc.
Initial Data from Phase 1 Multiple-Ascending Dose Trial of DT-216 for Friedreich Ataxia Expected in the Third Quarter of 2023 Progress Across GeneTAC™ Small Molecule Pipeline with IND Submissions...
Viridian Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
May 09, 2023 16:01 ET
|
Viridian Therapeutics, Inc
- Topline data from proof-of-concept study of VRDN-001 in patients with chronic thyroid eye disease (TED) are expected in June/July 2023 - - Selection of lead subcutaneous (SC) program in TED...
Sight Sciences Announces 12-month Results from the First Minimally Invasive Glaucoma Surgery (MIGS) Comparative Analysis of Real-World Data (RWD) from the American Academy of Ophthalmology IRIS® Registry
May 06, 2023 11:30 ET
|
Sight Sciences, Inc.
MENLO PARK, Calif., May 06, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on developing and commercializing innovative technology that enables...
Global Advanced Ophthalmology Technology Market Report 2023: Government Initiatives to Raise Awareness and Control Visual Impairment Drives Growth
May 04, 2023 05:08 ET
|
Research and Markets
Dublin, May 04, 2023 (GLOBE NEWSWIRE) -- The "Global Advanced Ophthalmology Technology Market by Type (Diagnostic, Therapeutic), End-user (ASCs, Hospitals, Ophthalmic Clinic) - Cumulative Impact of...
Cross Keys Capital Advises Regional Cancer Care Associates in Its Strategic Relationship with The US Oncology Network
May 03, 2023 15:51 ET
|
Cross Keys Capital, LLC.
Fort Lauderdale, Florida, May 03, 2023 (GLOBE NEWSWIRE) -- Cross Keys Capital, a leading independent investment banking firm providing M&A advisory services to physician group practices and...
Iridex to Report First Quarter Financial Results on May 11, 2023
April 27, 2023 16:05 ET
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., April 27, 2023 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and...
Surgical Robots Market to be Worth $25.47 Billion by 2030 – Exclusive Report by Meticulous Research®
April 27, 2023 10:00 ET
|
Meticulous Market Research Pvt. Ltd.
Redding, California, April 27, 2023 (GLOBE NEWSWIRE) -- According to a new market research report titled, “Surgical Robots Market by Product & Service (Surgical Instruments & Accessories,...
Clearside Biomedical Presents Compelling Data at The Association for Research in Vision and Ophthalmology (ARVO) 2023 Annual Meeting
April 27, 2023 07:05 ET
|
Clearside Biomedical, Inc.
ALPHARETTA, Ga., April 27, 2023 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through...
Ashvattha Therapeutics Presents Preclinical Data on anti-VEGF Nanomedicine D-4517.2 at the 2023 ARVO Annual Meeting
April 26, 2023 13:30 ET
|
Ashvattha Therapeutics
Data demonstrated that a single oral dose of D-4517.2 significantly reduced choroidal neovascularization (CNV) lesions to a level comparable to D-4517.2 delivered subcutaneously and Aflibercept...